Michael Higgins analyst LADENBURG

Currently out of the existing stock ratings of Michael Higgins, 49 are a BUY (89.09%), 6 are a HOLD (10.91%).

Michael Higgins

Work Performance Price Targets & Ratings Chart

Analyst Michael Higgins works at LADENBURG with a stock forecast success ratio of 44.38% fulfilled within 176.94 days on average.

Michael Higgins’s has documented 120 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on RYTM, Rhythm Pharmaceuticals at 05-Jan-2024.

Wall Street Analyst Michael Higgins

Analyst best performing recommendations are on NVAX (NOVAVAX).
The best stock recommendation documented was for NVAX (NOVAVAX) at 5/14/2020. The price target of $50 was fulfilled within 4 days with a profit of $11.7 (30.55%) receiving and performance score of 76.37.

Average potential price target upside

ACHV Achieve Life Sciences NVAX Novavax PHGE Biomx RYTM Rhythm Pharmaceuticals ZYNE Zynerba Pharmaceuticals ACRX AcelRx Pharmaceuticals EIGR Eiger Biopharmaceuticals NTEC Intec Pharma Ltd SCYX Scynexis ARCT Arcturus Therapeutics Holdings PTN Palatin Technologies ARTL Artelo Biosciences SAGE Sage Therapeutic VRDN Viridian Therapeutics ZGNX Zogenix ATXS Astria Therapeutics MRNS Marinus Pharmaceuticals SVRA Savara

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

18

$13.64 (312.84%)

20 days ago

0/4 (0%)

$13.42 (293.01%)

Buy

4 months 9 days ago

1/1 (100%)

$-45.93 (-79.19%)

189

Buy

19

$14.64 (335.78%)

31

10 months 21 days ago

0/3 (0%)

$12.8 (206.45%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Michael Higgins is most bullish on?

Potential upside of $13.2 has been obtained for RYTM (RHYTHM PHARMACEUTICALS)

Which stock is Michael Higgins is most reserved on?

Potential downside of -$0 has been obtained for ACHV (ACHIEVE LIFE SCIENCES)

What Year was the first public recommendation made by Michael Higgins?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?